Renal Lipidosis in Horses and Donkeys: 25 Cases (2008–2022)

Renal Lipidosis in Horses and Donkeys: 25 Cases (2008–2022)

ABSTRACT Background Renal lipidosis is a well‐documented histologic finding in humans and small animals with renal and metabolic disorders, but it is not well described in equids. Objective To describe the signalment, clinicopathologic indices, and postmortem findings of equids with a histologic dia...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kali Slavik, Susan Bender, Leslie Sharkey, Rose Nolen‐Walston
Format:	Article
Language:	English
Published:	Wiley 2025-03-01
Series:	Journal of Veterinary Internal Medicine
Subjects:	hyperlactatemia hyperlipemia hypertriglyceridemia nephrotoxicity obesity PPID
Online Access:	https://doi.org/10.1111/jvim.70072
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association Between Adrenocorticotropic Hormone Concentration and Clinical Signs of Pituitary Pars Intermedia Dysfunction in Swiss and Austrian Equids
by: Nathalie Fouché, et al.
Published: (2025-03-01)

Lactic acidosis in hemophagocytic syndrome: diagnostic and therapeutic challenges in the intensive care unit—a case series
by: Tianqi Xu, et al.
Published: (2025-08-01)

Associations between oxygen delivery and cardiac index with hyperlactatemia during cardiopulmonary bypassCentral MessagePerspective
by: Ignazio Condello, PhD, et al.
Published: (2020-06-01)

Lipid-lowering effectiveness of a Russian generic of atorvastatin in patients with various hyperlipidaemia phenotypes
by: P. P. Malyshev, et al.
Published: (2009-12-01)

Lipemia Retinalis in a 25-day Old Neonate : A case report
by: Santosh Kumar Mahapatra, et al.
Published: (2020-07-01)

Sulforaphane attenuates CD36-mediated platelet hyperreactivity through modulating cAMP/PKA/NOX2 signaling in hyperlipidemic conditions
by: Weiqi Li, et al.
Published: (2025-07-01)

Skin manifestations of secondary dyslipidemia: a case report
by: Z. F. Kim, et al.
Published: (2022-09-01)

Russian extreme hypertriglyceridemia registy (REGGI): a call to action
by: U. V. Chubykina, et al.
Published: (2024-12-01)

Comparing efficacy of fibrates and statins in isolated and combined hypertriglyceridemia and various types of oxidative metabolism
by: G. S. Mal’
Published: (2005-06-01)

The potential role of adjunctive ascorbic acid in the prevention of colistin-induced nephrotoxicity in critically ill patients: A retrospective study
by: Khalid Al Sulaiman, et al.
Published: (2022-12-01)

Natural dynamics of hypertriglyceridemia: incidence, regression, mortality from cardiovascular diseases and all causes (according to the results of a 17-years prospective study)
by: I. V. Dolgalyov, et al.
Published: (2011-12-01)

Rates of acute pancreatitis and cardiovascular events among adults with severe or extreme hypertriglyceridemia in US clinical practice
by: Asia Sikora Kessler, et al.
Published: (2025-07-01)

Hypertriglyceridemia — current status of the problem. Part I: risks, physiology and pathophysiological aspects, classification and diagnostic problems
by: A. A. Semenkin, et al.
Published: (2025-02-01)

Kidney Toxicity of Drugs for the Heart: An Updated Perspective
by: Carlo Caiati, et al.
Published: (2025-03-01)

Changes in Cardiovascular Risk Factors in Residents of the Siberian Region (According to Epidemiological Studies)
by: G. V. Artamonova, et al.
Published: (2021-07-01)

Angiopoietin-Like Protein Family-Mediated Functions in Modulating Triglyceride Metabolism and Related Metabolic Diseases
by: Sen Yang, et al.
Published: (2025-03-01)

Calcium oxalate nephrosis in a cat
by: Ana Laura Paulino Leite Gomes, et al.
Published: (2024-04-01)

Novel Hypericin-loaded nanoparticles as a new drug delivery system ameliorate olanzapine-induced early renal injury and oxidative stress: In vitro and in vivo approaches
by: Abeer M. Abd El-Hameed, et al.
Published: (2025-05-01)

Altered mental status caused by hypertriglyceridemia in an adolescent
by: I. C. Olakunle, et al.
Published: (2024-12-01)

Trends in dyslipidemia prevalence among Uyghur adults of different genders in China: a retrospective cohort study
by: Gulinigaer Maimaitituersun, et al.
Published: (2025-05-01)

The combined associations of excess body weight, hypertension, and hypertriglyceridemia with hyperglycemia among nondiabetic older adults in regional China
by: Xiaojun Ouyang, et al.
Published: (2025-08-01)

Association between lipid profiles and platelet indices in middle-aged and older Chinese: a population-based cross-sectional study
by: Yanbo Li, et al.
Published: (2025-07-01)

The Effect of Dapagliflozin, a Sodium–Glucose Co-Transporter 2 Inhibitor, on Vancomycin-Induced Nephrotoxicity in Rats
by: Seyhmus Tan, et al.
Published: (2025-06-01)

The hydroalcoholic extract of Nasturtium officinale protectively inhibits apoptotic and inflammatory pathways in hepato- and nephrotoxicity: An in vivo study
by: Sevil Soudkhah, et al.
Published: (2025-06-01)

Manganese-Induced Nephrotoxicity Is Mediated through Oxidative Stress and Mitochondrial Impairment
by: Milad Niknahad, et al.
Published: (2020-06-01)

Colistin nephrotoxicity in critically ill patients after implementation of a new dosing strategy
by: Ayse Serra Ozel, et al.
Published: (2019-10-01)

Neoplastic and non-neoplastic swellings of the external genitalia in horses and donkeys: clinical, histopathological, and treatment outcomes
by: El-Sayed El-Shafaey, et al.
Published: (2025-08-01)

Optimal exposure targets for vancomycin in the treatment of neonatal coagulase-negative Staphylococcus infection: A retrospective study based on electronic medical records
by: Quanyao Chen, et al.
Published: (2022-05-01)

Corynoxeine Supplementation Ameliorates Colistin-Induced Kidney Oxidative Stress and Inflammation in Mice
by: Yue Liu, et al.
Published: (2025-05-01)

NEW EVIDENCES OF POSSIBILITY OF OMEGA-3 ACIDS USE FOR MYOCARDIAL INFARCTION SECONDARY PREVENTION
by: A. I. Martinov, et al.
Published: (2016-01-01)

Association of hypertriglyceridemia with risk factors for cardiovascular and renal complications in individuals with high cardiovascular risk
by: I. T. Murkamilov, et al.
Published: (2023-03-01)

Nephroprotective Effects of Fraxinus Hookeri Wenz. Against Renal Toxicity and DNA Oxidative Damages Induced by CCl4 in Rats
by: Raheela Sarwar, et al.
Published: (2025-08-01)

Animal models of chronic kidney disease: The missing piece of the puzzle for the development of new therapeutic options
by: Ilić Miloš, et al.
Published: (2025-01-01)

Synergistic impact of aflatoxin and ochratoxin A exposure in Charles foster rats: a toxicological study
by: Kanchan Gopal Choudhary, et al.
Published: (2025-08-01)

Through its genoprotective, mitochondrial bioenergetic modulation, and antioxidant effects, Fucoxanthin and its metabolite minimize Ochratoxin A-induced nephrotoxicity in HK-2 human kidney cells
by: Ekramy M. Elmorsy, et al.
Published: (2025-07-01)

Adverse effects of immunosuppressive therapy after kidney transplant
by: S. V. Popov, et al.
Published: (2025-03-01)

Prevalence of Strongyle Infection and Associated Risk Factors in Horses and Donkeys in and around Mekelle City, Northern Part of Ethiopia
by: Wossene Negash, et al.
Published: (2021-01-01)

Correction of Hypertriglyceridemia as the Way to Reduce Residual Risk in Diseases Caused by Atherosclerosis. Conclusion of the Advisory Board of the Russian Society of Cardiology, the Russian Scientific Medical Society of Therapists, the Eurasian Association of Therapists, the Russian National Atherosclerosis Society, the Russian Association of Endocrinologists, and the National League of Cardiologic Genetics
by: G. P. Arutyunov, et al.
Published: (2019-05-01)

Analysis of Pharmacokinetic Parameters of Acetylsalicylic Acid for Prediction of Potential Nephrotoxic Effects
by: L. M. Krasnykh, et al.
Published: (2021-12-01)

Innovative nanostructured lipid-particles of apocynin and clove oil tagged with Chitin oligosaccharide for amelioration of tacrolimus-induced nephrotoxicity
by: Amir Elsayed Maghrabia, et al.
Published: (2025-08-01)